Psychedelics May Help with Depression Treatment for Some

A newly published study on psychedelics is reshaping how clinicians think about depression treatment and making clear that psychedelic-assisted therapy isn’t fit for everyone.

Researchers from Charité–Universitätsmedizin Berlin collaborated with colleagues in France and the U.S. to survey 158 therapists who administer psychedelic-assisted therapy using substances like psilocybin and LSD. They wanted to understand why some people living with treatment-resistant depression experience relief, while others see no improvement or even feel worse afterward.

For families and individuals researching mental health treatment facilities, the findings underscore how there’s no one-size-fits-all approach to behavioral health care. A person’s full clinical picture matters enormously. Psychedelic-assisted therapy, in particular, carries real risks for the wrong candidate, and the study’s authors stress it should never be approached as a casual or guaranteed fix.

Mental Health Connects to Addiction

One notable finding from the survey involves substance use. Therapists reported that people with a history of using cocaine, amphetamines, alcohol or cannabis tended to have less favorable outcomes from psychedelic-assisted therapy. This finding reinforces the belief that mental health conditions and substance use disorders rarely exist in isolation from one another. Treating one without addressing the other can limit results or even make a new treatment riskier rather than helpful.

The study also found that personality traits play a meaningful role in who’s a good candidate. People described as open to new experiences, able to form secure attachments, and capable of processing and “letting go” of difficult emotions tended to respond better. By contrast, therapists urged caution for folks with paranoid, schizoid or schizotypal traits, since they appeared more vulnerable to negative reactions. Outcomes for people with narcissistic, antisocial or borderline personality traits were harder to predict, suggesting more research and careful screening are needed.

Treatment Approaches Mentioned

The research clearly reinforced how psychedelic-assisted therapy isn’t a standalone “miracle cure,” and it can backfire for people who aren’t properly prepared or supported. Even though some states seek to fast-track the program, success depends heavily on the surrounding framework. Patients need to build trust with a therapist beforehand, set clear goals, undergo sessions in a controlled clinical setting, and receive structured follow-up care to process the experience afterward. 

Therapists working outside regulated clinical settings had more optimism about outcomes. But the researchers cautioned that supervised, evidence-based environments remain the safer path while this treatment is still considered experimental.

For the many people for whom psychedelics aren’t appropriate or available, the broader behavioral treatment centers landscape already relies on a well-established toolkit for treatment-resistant depression and co-occurring conditions, including behavior therapy, trauma-focused therapy, and medication management.

Understanding Dual Diagnosis

When a person lives with depression alongside a substance use—as one often influences the other—clinicians refer to this as a dual diagnosis or co-occurring disorder. This new research illustrates why the distinction matters so much. A person’s history with substances directly influences how they respond to mental health interventions, including emerging treatments like psychedelic-assisted therapy.

Integrated treatment generally produces better long-term outcomes than treating depression and substance use separately. The two conditions interact and reinforce each other, and recovery requires addressing both.

Treatment Options for Mental Health and Addiction

For people living with treatment-resistant depression and a co-occurring substance use history, care typically falls into two settings. Residential treatment centers offer 24-hour support, structured therapy schedules, and a substance-free environment for more severe needs or when home life lacks stability. Outpatient programs allow folks to continue therapy while living at home.

Evidence-based therapies remain central regardless of setting and the first-line, well-established options for most people. Behavioral therapy helps people identify and reframe negative emotions and thought patterns. Counselors often incorporate trauma-focused therapies since unresolved trauma frequently underlies both conditions.

Comprehensive Treatment Now

If you or someone you love is living with mental or behavioral disorders, care is available. A qualified provider can help determine which approach, conventional or otherwise, fits your specific situation. Many facilities now offer:

• Mental health treatment centers with programs specifically designed for treatment-resistant depression and anxiety disorders.
• Dual diagnosis treatment programs that address mental health and substance use together rather than separately.
• Facilities that treat depression and addiction through individualized, evidence-based care plans.

Call 800-908-4823 (Sponsored) to speak confidentially with an expert or browse our directory to find a treatment specialist anywhere in the country.

Author

Courtney Myers, MS

Read Bio

Courtney Myers has more than 15 years of experience in online writing and editing. Since graduating from N.C. State University with an MS in Technical Communication, she’s helped clients improve their visibility and reach through expert-level content creation. She specializes in addiction recovery and behavioral healthcare topics.

Editor

Peter Lee, PhD

Read Bio

Peter W.Y. Lee is a writer and historian of American history during the Cold War. His primary focus is the relationship between youth and popular culture and its impact on U.S. society during the twentieth century. He has published widely on how the public has used popular culture as a mechanism to address political and social shifts throughout time